Literature DB >> 32350059

Changing the strategy and culture of stroke awareness education in China: implementing Stroke 1-2-0.

Jing Zhao1,2, Xutong Li1, Xiaochuan Liu3, Yuming Xu4, Jihong Xu5, Anding Xu6, Yongjun Wang7,8, Renyu Liu9.   

Abstract

This project implemented the Stroke 1-2-0 stroke awareness programme across China and investigated its impact over a 2-year period. We initiated the Stroke 1-2-0 educational campaign and Stroke 1-2-0 special task forces (STF) across the nation. Massive media coverage, community-based educational sessions with videos and other related materials and induction of Stroke 1-2-0 STF were the major means of promotion. We delivered a survey at the end of 2016 and 2018 to evaluate the impact of our effort. A total of 3066 participants responded to the first survey in 2016, and 15 207 participants responded in 2018 across China. The acceptance rate for Stroke 1-2-0 versus FAST (an English-language stroke awareness tool) was 50.2% versus 19.1% in 2016, and changed significantly to 82.2% versus 8.0% in 2018 (p<0.001). Stroke 1-2-0 was well accepted by all ages and by people with different academic qualifications. Only 6.5% of survey respondents were aware that there was a therapeutic window for thrombolytic therapy in 2016, but this awareness increased significantly to 32.8% in 2018. Only 12.6% of people in 2016 indicated that they would send patients with stroke to the nearest hospital capable of performing thrombolytic therapy, but there was a nearly threefold increase (52.5%) in this number by 2018. More than 1000 major hospitals joined the Stroke 1-2-0 STF, and more than 20 000 'stroke warriors' have joined our stroke awareness improvement effort so far. Stroke 1-2-0 stroke awareness programme is well-implemented and accepted, and is generating profound improvement in stroke awareness in China. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  education; pre-hospital delay; stroke; therapeutic window; thrombolytic therapy

Year:  2020        PMID: 32350059     DOI: 10.1136/svn-2019-000324

Source DB:  PubMed          Journal:  Stroke Vasc Neurol        ISSN: 2059-8696


  7 in total

1.  Analysis of Time to the Hospital and Ambulance Use Following a Stroke Community Education Intervention in China.

Authors:  Jing Yuan; Minghui Li; Yang Liu; Xiaomo Xiong; Zhengbao Zhu; Fangyu Liu; Yong Wang; Wei Hu; Z Kevin Lu; Renyu Liu; Jing Zhao
Journal:  JAMA Netw Open       Date:  2022-05-02

2.  Impact of a health campaign on Chinese public awareness of stroke: evidence from internet search data.

Authors:  Man Cao; Tianjia Guan; Xueyan Han; Bingjie Shen; Baohua Chao; Yuanli Liu
Journal:  BMJ Open       Date:  2021-12-14       Impact factor: 2.692

3.  Evaluation of stroke health education for primary school students in Dali, China.

Authors:  Yunjuan Yang; Jing Dai; Jieqing Min; Zhizhong Song; Shun Zha; Litao Chang; Jiajia Chai; Youpei Yang; Yang Liu; Xin Zhang; Xiyun Wu; Yuwen Gong; Xin Wang; Fang Li; Haiyan Qin
Journal:  Front Public Health       Date:  2022-08-02

4.  Design and validation of a new scale for prehospital evaluation of stroke and large vessel occlusion.

Authors:  Yanqi Shao; Zheyu Zhang; Bo Jin; Jingsi Xu; Deqing Peng; Yu Geng; Jungen Zhang; Sheng Zhang
Journal:  Ther Adv Neurol Disord       Date:  2022-06-30       Impact factor: 6.430

5.  To use stroke 911 to improve stroke awareness for countries where 911 is used as an emergency phone number.

Authors:  Renyu Liu; Jing Zhao; Xiaobin Li; Steven Messe; Marc Fisher; Anthony Rudd
Journal:  CNS Neurosci Ther       Date:  2022-08-04       Impact factor: 7.035

6.  The global impact of COVID-19 on acute stroke care.

Authors:  Renyu Liu; Jing Zhao; Marc Fisher
Journal:  CNS Neurosci Ther       Date:  2020-07-29       Impact factor: 7.035

7.  Poor awareness of stroke educational tools among older adults in China.

Authors:  Ling Ling; Zhongcheng Li; Sichen Yao; Xiaochuan Liu; Jing Zhao
Journal:  Brain Behav       Date:  2021-09-14       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.